The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling
Open Access
- 1 January 1997
- journal article
- Published by Elsevier BV
- Vol. 272 (5), 2927-2935
- https://doi.org/10.1074/jbc.272.5.2927
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Differential Modulation of Mitogen-activated Protein (MAP) Kinase/Extracellular Signal-related Kinase Kinase and MAP Kinase Activities by a Mutant Epidermal Growth Factor ReceptorPublished by Elsevier BV ,1995
- Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastomaInternational Journal of Cancer, 1994
- Tissue-Specific Transformation by Oncogenic Mutants of Epidermal Growth Factor ReceptorCritical Reviews™ in Oncogenesis, 1994
- Immunodetection of the Ligand-Activated Receptor for Epidermal Growth FactorGrowth Factors, 1991
- Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor functionCell, 1990
- c-erbB activation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptorCell, 1985
- Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitroCell, 1985
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 1985
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984
- Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenesCell, 1983